Syncromune® Inc. Expands Scientific Advisory Board with Addition of Prominent Oncology Trailblazer James Armitage, M.D.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Oct 31, 2023--
Source: eagletribune.com
📰 Syncromune Inc News
Syncromune Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Syncromune Inc. Real-time updates on events, politics, business and more.
Syncromune® Inc., Appoints Jonathan Lewis, M.D., Ph.D., A Renowned Immune Therapy Pioneer, as Chief Medical Officer
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jul 12, 2023--
Source: valdostadailytimes.com
3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2%
/PRNewswire/ -- Chinese leading biopharmaceutical company 3SBio (01530.HK) today announced its 2022 annual results. In 2022, 3SBios core biopharmaceutical...
United States National Engineering Research Center Cosmo Pharmaceuticals 3sbio Inc Chengdu Kelingyuan Pharmaceutical Technology Co Ltd National Reimbursement Drug List
Source: prnewswire.com